Prethy Rao, MD
Ophthalmology · Bellaire, TXNPI 1982967998
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $56,870 of the $85,112 with a category attached, or 66.8%. 21 manufacturers reported payments, led by Bausch & Lomb Americas Inc. at 58.0% of the total. 2025 is the largest year on record at $34,694, more than ten times the $149 reported in 2019. Among ophthalmology clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 164 payments — averaging $518.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Bausch & Lomb Americas Inc.$49K
- Regeneron Healthcare Solutions, Inc.$17K
- Genentech USA, Inc.$6K
- Genentech, Inc.$5K
- Dutch Ophthalmic, USA$3K
- Eyepoint US, Inc.$3K
- plus $2K from 15 others
Across 55 payments — averaging $5243.94 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Janssen Research & Development, LLC$248K
- Genentech, Inc.$41K
What the payments were for
- Consulting fees$56,87067%
- Speaking & faculty fees$5,6097%
- Travel & lodging$15,72118%
- Food & beverage$6,9128%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Bausch & Lomb Americas Inc. | 52 | $49,325 |
| Regeneron Healthcare Solutions, Inc. | 30 | $17,365 |
| Genentech USA, Inc. | 35 | $6,144 |
| Genentech, Inc. | 4 | $4,696 |
| Dutch Ophthalmic, USA | 4 | $2,955 |
| Eyepoint US, Inc. | 8 | $2,863 |
| Regeneron | 4 | $353 |
| AbbVie(2 entities) | 7 | $280 |
| Alcon | 2 | $241 |
| Apellis Pharmaceuticals, Inc. | 5 | $230 |
| Novartis | 2 | $130 |
| Samsara Vision | 1 | $120 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $118 |
| Oculus Surgical Inc. | 1 | $87 |
| Biogen | 2 | $54 |
| Astellas US LLC | 1 | $44 |
| Springworks Therapeutics, Inc. | 1 | $27 |
| Boston Scientific | 1 | $24 |
| Harrow Eye, LLC | 1 | $20 |
| Alimera Sciences, Inc. | 1 | $19 |
| Eyevance Pharmaceuticals LLC | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- STELLARIS$35,199
- STELLARIS ELITE$21,223
- EYLEA HD$15,949
- SURGICAL MISC$11,309
- VABYSMO$9,808
- EVA, combined machine$2,917
- EYP-1901$1,700
- YUTIQ$936
- EYLEA$764
- SUSVIMO$289
- Constellation$241
- OZURDEX$149
- Implantable Miniature Telescope$120
- Syfovre$111
How this compares
$85,112 in reported general payments places this provider in the 95th percentile of 1,355 ophthalmology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 120 | $5,732 |
| Ketorolac Tromethamine | 99 | $2,334 |
| Bromfenac Sodium | 14 | $1,422 |
| Difluprednate | 14 | $1,394 |
| Atropine Sulfate | 39 | $963 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 27 | $534 |
| Ofloxacin | 39 | $416 |
| Brimonidine Tartrate | 13 | $254 |
| ErythromycinErythromycin Base | 16 | $195 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Bellaire
- Charles WykoffBellaire$1.5M
- Otis WaltonBellaire$311K
- Richard YeeBellaire$195K
- Hasenin Al-KhersanBellaire$76K
- Michael SingerSan Antonio$1.8M
- Oluwatosin SmithDallas$1.5M
- John MichelettiHouston$916K
- Davinder GroverDallas$705K
- Christina WengHouston$676K
- Peter ChangHouston$656K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.